secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001683168-25-002140
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals regains Nasdaq compliance; subject to one-year monitoring period
--------------------------------------------------------------------------------

- Nasdaq letter dated March 31, 2025 confirms regained compliance with $1.00 bid price rule.
- Company subject to Mandatory Panel Monitor for one year from letter date.
- If noncompliance occurs within monitoring period, no additional cure period allowed; delisting process begins.
- Previous reverse stock splits (>250:1 cumulative) disqualified company from standard compliance period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825002140/0001683168-25-002140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825002140/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-002140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer